Head, The Molecular Pharmacology Group, INSERM Bordeaux Cancer Center
Bordeaux University, France
Following a PhD in Biochemistry and Molecular Biology and a postdoctoral stay in the laboratory of Molecular Pharmacology (Dr Y. Pommier) at the National Cancer Institute, Dr Pourquier acquired a solid experience in the field of DNA topoisomerases and their inhibitors used in cancer chemotherapy. In 2001 he obtained a senior investigator position at INSERM. He is currently the head of the molecular pharmacology group of the INSERM U916 unit at the Bergonié Cancer Institute of Bordeaux, France.
He is developing translational research programs in order to identify alternative therapies for the treatment of castration-resistant prostate cancers and new markers of sensitivity to anticancer drugs that are used or developed in that indication.